Companies · Other Health Care

Ventrix, Inc.

SAN DIEGO · Other Health Care

Diligence memoA one-page analyst read on Ventrix, Inc. — recommendation, valuation, rhythm, risks.
$5.3M
Total raised · real
2
Rounds
35.1×
Latest step-up
Top 36%
Sector rank · raised
Series A
Latest stage · inferred · Thu May 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time)

Ventrix, Inc. looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.90× the median modeled value of Series A Other Health Care companies in 2010–2012 (199 peers) — value vs value, same stage and era.
  • Within the normal band (90% of peer median) for its niche.
Dormant
  • Last raise 14.1 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Ventrix, Inc. is one of 5377 Other Health Care companies tracked from SAN DIEGO. By capital raised it ranks mid-pack (ahead of 65% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MPre-Seed · 2010-07-08 Raised $147K (real) Modeled valuation $4.5M (est)$147K$4.5MPre-Seed2010Series A · 2012-05-31 Raised $5.2M (real) Modeled valuation $104M (est)$5.2M$104MSeries A2012+$5.2MCumulative $5.3M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$147K · 2010
Series A$5.2M · 2012no Seed on file

Stages are modeled from round size (public records carry no series label). No record for: Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$104.2M
Base estimate est.
$6.6M
Conservative case
$566.5M
Upside case
$23.5M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $4.5M · 2010-07-082010Series A · modeled $104.2M · 2012-05-312012
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
6.0 yr
Elapsed time used
14.1 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
23 mo
Avg between rounds
$2.8M/yr
Capital velocity
16.0 yr
On record since
2010
First round
2
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 2.2× above median
This company$5.3M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.9× of median
This company$5.2M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 4.7× above median
This company$104.2M
Sector median$22.1M

Raised more than 65% of sector peers (real $). Modeled value above 80% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #115 of 199.

This companyCohort peer
$10.0M$100.0M$1.0B$1.0M$10.0M$100.0MCapital raised (log)Barrx Medical Inc · Series A Raised $15.0M · modeled $302.7M (est)Icad Inc · Series A Raised $27.1M · modeled $302.7M (est)Cas Medical Systems Inc · Series A Raised $16.9M · modeled $302.7M (est)Cardiosolutions Inc · Series A Raised $18.5M · modeled $300.3M (est)Ophthonix Inc · Series A Raised $24.7M · modeled $283.4M (est)FMS Watertown, LLC · Series A Raised $13.7M · modeled $277.2M (est)Flowood Vascular Access, LLC · Series A Raised $13.7M · modeled $277.2M (est)Cardiovascular Systems Inc · Series A Raised $58.5M · modeled $272.4M (est)HemaSource Holdings LLC · Series A Raised $13.5M · modeled $272.2M (est)OMNI Home Health Acquisition, LLC · Series A Raised $12.6M · modeled $253.2M (est)Integrated Sleep Holdings Inc · Series A Raised $12.4M · modeled $249.9M (est)AngioScore Inc. · Series A Raised $12.0M · modeled $242.2M (est)Ventrix, Inc. (this company) Raised $5.3M · modeled $104.2M (est)Ventrix, Inc.
CompanyStageRaised · realValue · estvs peer med.
Barrx Medical IncSeries A$15.0M$302.7M2.60×
Icad IncSeries A$27.1M$302.7M2.60×
Cas Medical Systems IncSeries A$16.9M$302.7M2.60×
Cardiosolutions IncSeries A$18.5M$300.3M2.58×
Ophthonix IncSeries A$24.7M$283.4M2.44×
FMS Watertown, LLCSeries A$13.7M$277.2M2.38×
Flowood Vascular Access, LLCSeries A$13.7M$277.2M2.38×
Cardiovascular Systems IncSeries A$58.5M$272.4M2.34×
HemaSource Holdings LLCSeries A$13.5M$272.2M2.34×
OMNI Home Health Acquisition, LLCSeries A$12.6M$253.2M2.18×
Integrated Sleep Holdings IncSeries A$12.4M$249.9M2.15×
AngioScore Inc.Series A$12.0M$242.2M2.08×
Ventrix, Inc. this companySeries A$5.3M$104.2M0.90×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$147K2010-07-08$817K$4.5M90%
Series A$5.2M2012-05-31$23.5M$104.2M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$147K2010-07-08
    • First recorded raise — entered as Pre-Seed.
  2. Series A$5.2M2012-05-31
    • Raised again after 23 mo — slower than the ~14 mo sector norm.
    • Round 35.1× larger than the prior — scaling up.
Intelligence
2014 ~Q2
Modeled next raise · ~23mo cadence
$15.5M
Modeled next size est.range $10.1M$24.8M
35.1×
Last step-up
$2.8M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
ADAM KINSEY1 other2010-07
Adam M. Kinsey2012-05
Karen L. Christman2010-07
Registry & provenance

Ventrix, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1496821
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
BlueStep Systems, LLCOther Health CareSeries A$5.3M$107.1Msame sector · same stage
Unilife Medical Solutions LtdOther Health CareSeries A$5.3M$107.5Msame sector · same stage
XCath, Inc.Other Health CareSeries A$5.3M$107.6Msame sector · same stage
Integrated Biopharma IncOther Health CareSeries A$5.3M$108.0Msame sector · same stage
USRC Skypark, LLCOther Health CareSeries A$5.4M$108.0Msame sector · same stage
Fannin Partners, LLCOther Health CareSeries A$5.3M$105.9Msame sector · same stage
Edmonds Memory Care, LLC, a Delaware Ltd liability CoOther Health CareSeries A$5.2M$88.1Msame sector · same stage
Fresenius Vascular Care Mishawaka MSO, LLCOther Health CareSeries A$5.4M$108.7Msame sector · same stage
Frequently asked
How much funding has Ventrix, Inc. raised?
Ventrix, Inc. has raised approximately $5.3M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Ventrix, Inc.'s estimated valuation?
Provath's modeled valuation for Ventrix, Inc. is approximately $104.2M (modeled range $6.6M–$566.5M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Ventrix, Inc. at?
Ventrix, Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Thu May 31.
What does Ventrix, Inc. do and where is it based?
Ventrix, Inc. operates in the Other Health Care sector, based in SAN DIEGO.
Explore related

See where Ventrix, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Ventrix, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.